PLMA_1170x120_7-2-21

Amneal Pharmaceuticals

Amneal’s Chintu Patel to keynote LIU Pharmacy graduation

Amneal’s Chintu Patel to keynote LIU Pharmacy graduation

BROOKLYN, N.Y. — Amneal Pharmaceuticals co-chief executive officer Chintu Patel will be the featured keynote speaker at the commencement ceremony for Long Island University’s Arnold and Marie Schwartz College of Pharmacy and Health Sciences. The event will be held on May 7 at the Tilles Center for the Performing Arts on the LIU Post campus

Amneal releases Nasonex generic, its first spray

Amneal releases Nasonex generic, its first spray

BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has launched mometasone furoate nasal spray, which marks the company’s first pharmaceutical product in spray form. Amneal said its mometasone furoate product, a generic version of Nasonex, is available in 50 mcg/spray strength and packaged in a white, high-density, polyethylene bottle fitted with a white, metered-dose, manual spray pump

Amneal ships Lotronex generic

Amneal ships Lotronex generic

BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has released alosetron hydrochloride tablets, a treatment for irritable bowel syndrome (IBS) in women. Amneal said its alosetron hydrochloride product, a generic version of Lotronex from Sebela Pharmaceuticals Inc., comes in 0.5-mg and 1-mg strengths and began shipping in 30-count bottles through wholesalers, distributors and directly to the trade

Amneal set to release Yuvafem

Amneal set to release Yuvafem

BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC next month plans to begin shipping Yuvafem 10-mcg estradiol vaginal inserts, a treatment for menopausal symptoms. Amneal said Monday that its product represents the first generic equivalent of Vagifem from Novo Nordisk. Yuvafem delivers the same low dose of vaginal estrogen in a preloaded, single-use, disposable applicator. Amneal said

Amneal adds to women’s health lineup

Amneal adds to women’s health lineup

BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has expanded its portfolio of women’s health products with the release of Femynor, a birth control pill. Amneal said Femynor (norgestimate and ethinyl estradiol tablets, 0.25 mg/0.035 mg) is a generic version of Ortho-Cyclen 28 from Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Femynor is sold in a

Amneal wins HDA generics manufacturer award

Amneal wins HDA generics manufacturer award

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has been recognized as a top generic drug manufacturer by the Healthcare Distribution Alliance (HDA). Amneal said that this week it received the Distribution Industry Award for Notable Achievements in Healthcare (DIANA) for Generic Pharmaceutical Product Manufacturer, for the $100 million-plus sales to health care distributors category. HDA presented the

Amneal earns ‘Company of the Year’ honors

Amneal earns ‘Company of the Year’ honors

BRIDGEWATER, N.J. — Amneal Pharmaceuticals won the award for “Company of the Year, Americas” at the 2015 Global Generics and Biosimilars Awards held in Madrid, Spain. Amneal said late Thursday that it was the second straight year the company was recognized by Generics Bulletin, a global newsletter for the generic drug and biosimilars industries. In

Amneal forms biosciences unit

Amneal forms biosciences unit

BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has formed Amneal Biosciences, a new business unit. Amneal said Tuesday that the new subsidiary will focus exclusively on the commercialization of high-barrier-to-entry generic drugs and specialty pharmaceuticals — such as injectables, oncologics and biosimilars — health care providers worldwide. “Having a dedicated company focused on the unique needs and

First Abilify oral solution generics released by Lannett, Amneal

First Abilify oral solution generics released by Lannett, Amneal

NEW YORK — Lannett Co. and Amneal Pharmaceuticals LLC have launched the first generic versions of Abilify oral solution (aripiprazole 1 mg/ml), Otsuka Pharmaceutical’s antidepressant drug. Lannett said Tuesday that its Silarx Pharmaceuticals subsidiary received Food and Drug Administration for its generic version of Abilify oral solution. “Our generic aripiprazole 1 mg/ml oral solution product